ClinicalTrials.Veeva

Menu

Specimen Banking From Patients With Lung Cancer

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Enrolling

Conditions

Lung Neoplasms

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT01585675
04-0688.cc
P50CA058187 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Full description

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

Enrollment

2,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
  2. Oral and written informed consent

Exclusion criteria

1. Any individual who does not give oral and written consent for participation

Trial design

2,000 participants in 1 patient group

Diagnosis/treatment of lung cancer
Description:
Specimen Banking

Trial contacts and locations

1

Loading...

Central trial contact

Brandi Kubala

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems